DKK1 and rheumatoid arthritis: In this regard, treatment with anti-Dkk-1 antibodies seems promising: in mouse models of RA, anti-Dkk-1 antibodies were able to block inflammatory bone erosions, as demonstrated by radiographic and histopathological examinations, due to a decreased osteoclast formation in the affected joints [22].